BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 17072343)

  • 1. Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells.
    Basaki Y; Hosoi F; Oda Y; Fotovati A; Maruyama Y; Oie S; Ono M; Izumi H; Kohno K; Sakai K; Shimoyama T; Nishio K; Kuwano M
    Oncogene; 2007 Apr; 26(19):2736-46. PubMed ID: 17072343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implications of the nuclear localization of Y-box-binding protein-1 and CXCR4 expression in ovarian cancer: their correlation with activated Akt, LRP/MVP and P-glycoprotein expression.
    Oda Y; Ohishi Y; Basaki Y; Kobayashi H; Hirakawa T; Wake N; Ono M; Nishio K; Kuwano M; Tsuneyoshi M
    Cancer Sci; 2007 Jul; 98(7):1020-6. PubMed ID: 17459055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer.
    Yahata H; Kobayashi H; Kamura T; Amada S; Hirakawa T; Kohno K; Kuwano M; Nakano H
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):621-6. PubMed ID: 12458343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.
    Fujii T; Kawahara A; Basaki Y; Hattori S; Nakashima K; Nakano K; Shirouzu K; Kohno K; Yanagawa T; Yamana H; Nishio K; Ono M; Kuwano M; Kage M
    Cancer Res; 2008 Mar; 68(5):1504-12. PubMed ID: 18316615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells.
    Lorenzato A; Biolatti M; Delogu G; Capobianco G; Farace C; Dessole S; Cossu A; Tanda F; Madeddu R; Olivero M; Di Renzo MF
    Exp Cell Res; 2013 Oct; 319(17):2627-36. PubMed ID: 23948303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of mRNA expression in drug-sensitive and drug-resistant gastric carcinoma cells is independent of YB-1 expression.
    Kurucz R; Belian E; Treue D; Lage H
    Anticancer Res; 2010 Feb; 30(2):693-8. PubMed ID: 20332492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of YB-1 on the regulation of micro RNA expression in drug-sensitive and drug-resistant gastric carcinoma cells.
    Belian E; Kurucz R; Treue D; Lage H
    Anticancer Res; 2010 Feb; 30(2):629-33. PubMed ID: 20332481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agents.
    Mantwill K; Köhler-Vargas N; Bernshausen A; Bieler A; Lage H; Kaszubiak A; Surowiak P; Dravits T; Treiber U; Hartung R; Gansbacher B; Holm PS
    Cancer Res; 2006 Jul; 66(14):7195-202. PubMed ID: 16849566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
    Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
    Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular localization and content of YB-1 protein in multidrug resistant tumor cells.
    Vaiman AV; Stromskaya TP; Rybalkina EY; Sorokin AV; Guryanov SG; Zabotina TN; Mechetner EB; Ovchinnikov LP; Stavrovskaya AA
    Biochemistry (Mosc); 2006 Feb; 71(2):146-54. PubMed ID: 16489918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
    Yu YN; Yip GW; Tan PH; Thike AA; Matsumoto K; Tsujimoto M; Bay BH
    Int J Oncol; 2010 Aug; 37(2):483-92. PubMed ID: 20596676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel.
    Fujita T; Ito K; Izumi H; Kimura M; Sano M; Nakagomi H; Maeno K; Hama Y; Shingu K; Tsuchiya S; Kohno K; Fujimori M
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8837-44. PubMed ID: 16361573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression.
    Bargou RC; Jürchott K; Wagener C; Bergmann S; Metzner S; Bommert K; Mapara MY; Winzer KJ; Dietel M; Dörken B; Royer HD
    Nat Med; 1997 Apr; 3(4):447-50. PubMed ID: 9095180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer.
    Dahl E; En-Nia A; Wiesmann F; Krings R; Djudjaj S; Breuer E; Fuchs T; Wild PJ; Hartmann A; Dunn SE; Mertens PR
    BMC Cancer; 2009 Nov; 9():410. PubMed ID: 19930682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Connection of intracellular protein YB-1 localization in cell cultures of human tumors with multidrug resistance].
    Rybalkina EIu; Stromskaia TP; Ovchinnikov LP; Stavrovskaia AA
    Vopr Onkol; 2013; 59(5):623-8. PubMed ID: 24260892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer.
    Kashihara M; Azuma K; Kawahara A; Basaki Y; Hattori S; Yanagawa T; Terazaki Y; Takamori S; Shirouzu K; Aizawa H; Nakano K; Kage M; Kuwano M; Ono M
    J Thorac Oncol; 2009 Sep; 4(9):1066-74. PubMed ID: 19648825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of proteasome inhibitor bortezomib on the expression of multidrug resistance genes and Akt kinase activity.
    Panischeva LA; Kakpakova ES; Rybalkina EY; Stavrovskaya AA
    Biochemistry (Mosc); 2011 Sep; 76(9):1009-16. PubMed ID: 22082269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIalpha and proliferating cell nuclear antigen expression in lung cancer.
    Gu C; Oyama T; Osaki T; Kohno K; Yasumoto K
    Anticancer Res; 2001; 21(4A):2357-62. PubMed ID: 11724293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer effects of chemokine receptor 4(CXCR4) gene silenced by CXCR4-siRNA in nude mice model of ovarian cancer.
    Liu W; Wang Y; Wang H; Wang A
    Cell Biochem Biophys; 2014 Dec; 70(3):1893-900. PubMed ID: 25149650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene.
    Ohga T; Uchiumi T; Makino Y; Koike K; Wada M; Kuwano M; Kohno K
    J Biol Chem; 1998 Mar; 273(11):5997-6000. PubMed ID: 9497311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.